Less Ads, More Data, More Tools Register for FREE

Pin to quick picksETX.L Share News (ETX)

  • There is currently no data for ETX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Woodford Raises GBP500 Million From Flurry Of London Share Sales (ALLISS)

Mon, 10th Jun 2019 13:33

LONDON (Alliance News) - Over the past week, fund manager Neil Woodford's Woodford Investment Management has conducted a fire sale of its stakes in 20 London-listed companies - raising in excess of GBP500 million - after taking the decision to suspend withdrawals from his equity income fund.

Woodford Investment manages three funds: LF Woodford Income Focus Fund, LF Woodford Equity Income Fund and London-listed Woodford Patient Capital Trust.

LF Woodford Equity Income Fund on Monday last week said the suspension was due to "an increased level of redemptions", with the fund now needing time to "reposition" its portfolio invested in unquoted and less liquid stocks into more liquid investments.

Neil Woodford appeared in a video suggesting his firm faced having to hold a fire sale in order to meet the demand for redemptions from his flagship Woodford Equity Income Fund, which was reported to have hit GBP10 million a day. The stock market guru insisted that his firm, Woodford Investment Management, has a strategy in place to stabilise the fund so holders would eventually be able to access their investments.

According to stock market filings, since Monday last week, Woodford Investment Management has reduced its holdings in the following London listings, in order of the minimum approximate gross value of each disposal:

- vehicle marketplace BCA Marketplace PLC, to 7.14% from 12.59%, GBP78.7 million;

- subprime lender Provident Financial PLC, to 18.43% from 23.44%, GBP65.7 million;

- housebuilder Countryside Properties PLC, to 10.20% from 15.00%, GBP65.1 million;

- guarantor loan company Amigo Holdings PLC, to 5.57% from 10.03%, GBP57.3 million;

- housebuilder Crest Nicholson Holdings PLC, to 10.01% from 15.08%, GBP48.0 million;

- property investor NewRiver REIT PLC, to 14.9% from 22.3% across three days, GBP46.3 million;

- intellectual property commercialisation company IP Group PLC to 14.08% from 19.00%, GBP40.7 million;

- online estate agent Purplebricks Group PLC, to 19.25% from 28.88% across three days, GBP31 million;

- retailer Card Factory PLC to below 5% from 8.94%, GBP26.1 million; at the end of May, this stake already had been lowered from 10.06%;

- construction firm Watkin Jones PLC, to below 5% from 9.19%, GBP22.2 million;

- construction materials firm Breedon Group PLC to below 5% from 6.83%, GBP21.4 million;

- media firm Time Out Group PLC to below 5% from 16.06%, GBP13.2 million;

- outsourcer and construction firm Kier Group PLC, to 15.87% from 20.01%, GBP10.3 million;

- intellectual property commercialisation company Allied Minds, to 23.22% from 28.21%, GBP9.4 million;

- ten-pin bowling site operator Ten Entertainment Group PLC to 5.54% from 10.08%, GBP6.5 million;

- housebuilder Barratt Developments PLC, to below 5% from 5.07%, GBP4.0 million;

- housebuilder Taylor Wimpey PLC, to below 5% from 5.07%, GBP3.9 million;

- respiratory disease-focused pharma firm Circassia Pharmaceuticals PLC to 24.47% from 28.03%, GBP2.5 million;

- housebuilder Redrow PLC, to below 5% from 5.07%, GBP1.4 million;

- defence firm Babcock International PLC, to below 5% from 5.03%, GBP721,809; and

- drug discovery company e-Therapeutics PLC to 14.11% from 17.89%, GBP193,196.

In total, these sales will have raised proceeds of around GBP550 million for Woodford Investment Management.

More News
8 May 2014 10:51

e-Therapeutics Trading Up As Brain Cancer Trial To Resume Recruitment

LONDON (Alliance News) - Shares in e-Therapeutics PLC were trading higher Thursday after it said that it had been cleared by the US Food and Drug administration to resume recruiting patients for its Phase Ia study of compound ETS2101 in brain cancer. The company had previously paused recrui

Read more
7 Apr 2014 12:25

UPDATE: e-Therapeutics Appoints Steve Medlicott Chief Financial Officer

LONDON (Alliance News) - e-Therapeutics PLC Monday said that it had appointed Steve Medlicott as Chief Financial Officer, following the resignation of Daniel Elger with immediate effect, also announced Monday. Medlicott had advised the company on its GBP40 million fund-raising in 2013. Medl

Read more
7 Apr 2014 10:57

e-Therapeutics's Chief Financial Officer Daniel Elger Resigns

LONDON (Alliance News) - e-Therapeutics PLC Monday said that Daniel Elger has resigned as Chief Financial officer and a director of the company, with immediate effect. e-Therapeutics said that the company's finances will be managed on an interim basis by Paul Stockdale, who has been the com

Read more
31 Mar 2014 12:50

REPEAT: UK MIDDAY BRIEFING: Babcock JV Wins GBP7 Billion Nuclear Contract

LONDON (Alliance News) - Babcock International Group is leading the FTSE 100 higher Monday after its Cavendish Fluor Partnership joint venture was selected as the preferred bidder for a GBP7 billion nuclear plant decommissioning contract.

The joint venture with Fluo

Read more
31 Mar 2014 12:45

UK MIDDAY BRIEFING: Babcock JV Wins GBP7 Billion Nuclear Contract

LONDON (Alliance News) - Babcock International Group is leading the FTSE 100 higher Monday after its Cavendish Fluor Partnership joint venture was selected as the preferred bidder for a GBP7 billion nuclear plant decommissioning contract.

The joint venture with Flou

Read more
31 Mar 2014 10:35

UK WINNERS & LOSERS: Babcock Leads FTSE 100 Risers; Insurers Rebound

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Monday.

-------

FTSE 100 - WINNERS

Babcock International Group, up 3.5%. The company said its Cavendish Fluor Partnership has

Read more
31 Mar 2014 08:33

e-Therapeutics Rises As It Gets Good Interim Drug Trial Results

LONDON (Alliance News) - e-Therapeutics PLC Monday said it had achieved positive interim results from a UK study evaluating the safety, dosing and anti-tumour activity of its ETS2101 drug in patients with advanced solid cancer tumours. In a statement, the company said that it had completed

Read more
26 Mar 2014 13:40

UK MIDDAY BRIEFING: Government Completes 2nd Lloyds Bank Stake Sale

LONDON (Alliance News) - The UK government has raised a further GBP4.20 billion from its second sale of Lloyds Banking Group PLC shares, meaning it has now recouped GBP7.41 billion of the roughly GBP21 million that taxpayers injected into the bank during the financial crisis.<

Read more
26 Mar 2014 11:30

UK WINNERS & LOSERS: Standard Life Leads FTSE 100 Risers

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Wednesday.

-------

FTSE 100 - WINNERS

Standard Life, up 5.2%. The company has agreed to buy Ignis Asset Mana

Read more
26 Mar 2014 11:03

e-Therapeutics Gains As Recruitment For Cancer Trial Resumes

LONDON (Alliance News) - Shares in e-Therapeutics PLC jumped Wednesday morning after the biotechnology company said it has received approval from MHRA to recommence recruitment of new patients into its ETS2101 phase Ia solid tumours trial. Recruitment for the trial was temporarily paused ov

Read more
24 Jan 2014 12:41

UK MIDDAY BRIEFING: Bank Of England Now Focused On Productivity

LONDON (Alliance News) - Bank of England Governor Mark Carney Friday signaled that rising productivity will now be the key factor that decides when the central bank will start to tighten monetary policy, and any tightening will be a slow, gradual process.

In a speech at the World Ec

Read more
24 Jan 2014 11:01

e-Therapeutics Temporarily Halts Recruitment In Trial Due To Drug Supply Issue

LONDON (Alliance News) - Shares in e-Therapeutics PLC dropped 16% Friday morning after it said that it was temporarily halting recruitment into its ETS2101 cancer trials due to a drug supply issue. e-Therapeutics said that there had been a practical issue with the stored drugs for the trial

Read more
24 Jan 2014 10:58

UK WINNERS & LOSERS: Cairn Falls As Indian Tax Department Gets In Touch

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Friday. ------- FTSE 100 - WINNERS Weir Group, up 0.2%. The engineering company said it had won a USD98 million, or GBP59 million, two-year contract to provide

Read more
7 Jan 2014 08:22

AIM IN BRIEF: H&T Says Profit As Expected, But Gold Price Has Hurt

Read more
31 Oct 2013 13:36

e-Therapeutics Starts Phase IIb Trial Of Depressive Disorder Treatment

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.